Related Experiment Videos
Structure of a human rhinovirus complexed with its receptor molecule
N H Olson1, P R Kolatkar, M A Oliveira
1Department of Biological Sciences, Purdue University, West Lafayette, IN 47907-1392.
Summary
Cryoelectron microscopy revealed how human rhinovirus 16 binds its cellular receptor, intercellular adhesion molecule 1. The virus-receptor interaction occurs within a deep surface "canyon," inaccessible to antibodies.
Area of Science:
- Structural Biology
- Virology
- Immunology
Background:
- Understanding virus-receptor interactions is crucial for developing antiviral therapies.
- Human rhinoviruses are a major cause of the common cold, utilizing specific cellular receptors for entry.
- Previous predictions suggested viral attachment sites are located in antibody-inaccessible regions.
Purpose of the Study:
- To determine the high-resolution structure of human rhinovirus 16 complexed with its cellular receptor, intercellular adhesion molecule 1 (ICAM-1).
- To structurally validate the proposed model of viral attachment within a surface cavity.
- To investigate the atomic basis of virus-receptor recognition.
Main Methods:
- Cryoelectron microscopy was employed to visualize the virus-receptor complex.
- Computational modeling and analysis were used to interpret the electron density maps.
- Comparison with homologous structures (human rhinovirus 14 and CD4) was performed.
Main Results:
- The structure revealed that ICAM-1 binds within a deep 'canyon' on the surface of human rhinovirus 16.
- This binding site is approximately 12-Å deep, confirming its inaccessibility to host antibodies.
- Atomic structures of homologous viral and receptor components showed high correspondence, validating the observed interactions.
Conclusions:
- The study provides direct structural evidence for the location of the viral attachment site in a protected cavity.
- This confirms the hypothesis that viruses exploit antibody-resistant sites for cellular receptor binding.
- The findings offer insights into the molecular mechanisms of rhinovirus infection and potential therapeutic targets.